Abstract:Tissue factor (TF), the primary initiator of the extrinsic coagulation cascade, is highly expressed by astrocytes surrounding blood vessels in the central nervous system. Using mouse models of hemorrhagic and ischemic stroke, we previously demonstrated that astrocyte TF plays a critical role in brain hemostasis while also contributing to neuronal damage. Importantly, using mice with different levels of astrocyte TF expression, we determined that an astrocyte TF activity around 5% of the wild type level was sufficient to limit bleeding in hemorrhagic stroke and at the same time was low enough to reduce infarct size and behavioral deficits in ischemic stroke, without increased hemorrhagic transformation. Therefore, we hypothesized that pharmacologic inhibition of TF may improve outcomes after ischemic stroke and have a wide safety margin. To test this hypothesis, C56Bl/6J mice were subjected to middle cerebral artery occlusion (MCAO) for 1 hour followed by 24 hours of reperfusion. Inhibitory rat anti- mouse TF antibody (1H1) and control IgG were administered as a bolus intraperitoneal injection immediately after ischemia. Inhibition of TF dose-dependently reduced brain infarct size in female mice (36.6±1.4% of total brain volume in IgG group [n=19] vs 28.3 ± 1.7% in 25mg/kg 1H1 group [n=9, p<0.01] and 18.5 ±2.3% in 75mg/kg 1H1 group [n=8, p<0.001]; mean±SEM). Importantly, 1H1 did not exacerbate hemorrhagic transformation during the reperfusion phase. Furthermore, TF inhibition significantly reduced microvascular thrombosis (analyzed by fibrin staining), expression of inflammatory markers in the injured brain (IL-6, MCP-1 and KC levels- analyzed by ELISA) and attenuated behavioral deficit after ischemic stroke. Subjecting male mice to the same MCAO condition resulted in partial lethality in IgG treated group (4 out of 6 mice died with 24 hours) which was prevented by 1H1 (25mg/kg) treatment (0 out of 5, Log-rank test p=0.031). Altogether, our data suggest that the overabundance of astrocyte TF expression resulted from selective pressure to limit intracerebral hemorrhage after traumatic brain injury, but in the modern era poses the additional risk of increased injury during ischemic stroke.

Thrombin increases the expression of cholesterol 25-hydroxylase in rat astrocytes after spinal cord injury

The role of thrombospondin-1 and transforming growth factor-β after spinal cord injury in the rat

Minocycline Reduces Intracerebral Hemorrhage-Induced Brain Injury

Thrombin Promotes the Expression of Thrombospondin-1 and ‐2 in a Rat Model of Intracerebral Hemorrhage

Thrombin Preferentially Induces Autophagy in Glia Cells in the Rat Central Nervous System

Inhibition of Astrocytic Carbohydrate Sulfotransferase 15 Promotes Nerve Repair after Spinal Cord Injury Via Mitigation of CSPG Mediated Axonal Inhibition

[Effect of Thrombin on Cultured Rat Cerebral Astrocyte Injured by Hypoxia/reoxygenation and Its Relationship with Inos].

AXL kinase-mediated astrocytic phagocytosis modulates outcomes of traumatic brain injury

Attenuation of Astrogliosis and Modulation of Endothelial Growth Factor Receptor in Lipid Rafts by Simvastatin after Traumatic Brain Injury

Effect of CLIP3 Upregulation on Astrocyte Proliferation and Subsequent Glial Scar Formation in the Rat Spinal Cord via STAT3 Pathway After Injury

Microglial depletion impairs glial scar formation and aggravates inflammation partly by inhibiting STAT3 phosphorylation in astrocytes after spinal cord injury

Argatroban promotes recovery of spinal cord injury by inhibiting the PAR1/JAK2/STAT3 signaling pathway

Increasing toll-like receptor 2 on astrocytes induced by Schwann cell-derived exosomes promotes recovery by inhibiting CSPGs deposition after spinal cord injury

D-dopachrome tautomerase activates COX2/PGE2 pathway of astrocytes to mediate inflammation following spinal cord injury

Optogenetic Activation of Astrocytes Reduces Blood-Brain Barrier Disruption Via IL-10 in Stroke.

Alteration of Thrombospondin-1 and -2 in Rat Brains Following Experimental Intracerebral Hemorrhage

Thrombin inhibits aquaporin 4 expression through protein kinase C-dependent pathway in cultured astrocytes

Abstract 398: Inhibition of Tissue Factor Reduces Thrombosis and Inflammation Without Increased Bleeding in a Mouse Model of Ischemic Stroke

Role of Cholesterol Metabolic Enzyme CYP46A1 and Its Metabolite 24S-Hydroxycholesterol in Ischemic Stroke

Effect of myelin debris on the phenotypic transformation of astrocytes after spinal cord injury in rats

Unresolved Excess Accumulation of Myelin-derived Cholesterol Contributes to Scar Formation after Spinal Cord Injury